文献速递炎症性肠病消化道肿瘤与早癌

ZEB1通过抑制DNA修复糖基化酶MPG促进炎症及炎症驱动性癌变

ZEB1 promotes inflammation and progression towards inflammation-driven carcinoma through repression of the DNA repair glycosylase MPG in epithelial cells.
PubMed 文献 · Gut · 2019-07-31

该研究利用溃疡性结肠炎(UC)患者样本、小鼠结肠炎与结直肠癌(CRC)模型及Zeb1和Mpg缺陷小鼠,发现ZEB1在UC和结肠炎小鼠结肠上皮中诱导表达;Zeb1缺陷小鼠部分抵抗实验性结肠炎,在炎症性CRC模型中肿瘤更少、DNA损伤标志物8-oxo-dG更低且MPG表达更高。机制上ZEB1直接结合MPG启动子并抑制其表达,且ZEB1在CRC细胞中诱导巨噬细胞产生ROS和IL1β,后者反过来降低CRC细胞MPG,形成正反馈环路促进DNA损伤并抑制DNA修复。

要点

  • ZEB1在UC和实验性结肠炎小鼠结肠上皮中表达上调。
  • Zeb1缺陷小鼠部分抵抗实验性结肠炎,炎症性CRC模型中肿瘤更少、8-oxo-dG更低、MPG更高。
  • ZEB1直接结合MPG启动子并抑制其表达,Zeb1/Mpg双缺陷可逆转Zeb1缺陷小鼠的炎症与肿瘤减少表型。

核心结论

  • ZEB1通过抑制上皮细胞中MPG促进结肠炎和炎症性CRC,为调控炎症及炎症相关癌症提供新的治疗策略思路。

研究设计与样本

  • 研究使用UC患者样本、结肠炎和CRC小鼠模型以及Zeb1缺陷和Mpg缺陷小鼠。
  • 样本分析方法包括免疫染色、qRT-PCR、染色质免疫沉淀、微生物群下一代测序和ROS检测。

主要发现

  • ZEB1在UC和结肠炎小鼠模型的结肠上皮中被诱导表达。
  • 与野生型对照相比,Zeb1缺陷小鼠部分免受实验性结肠炎影响,在炎症性CRC模型中肿瘤更少、8-oxo-dG水平更低且MPG表达更高。
  • 在CRC细胞中敲低ZEB1可抑制氧化应激(H2O2)和炎症细胞因子(IL1β)诱导的8-oxo-dG。
  • ZEB1直接结合MPG启动子并抑制其表达,该机制在遗传水平得到验证,Zeb1缺陷与Mpg缺陷小鼠杂交可逆转前者炎症和肿瘤发生减少的表型。
  • CRC细胞中的ZEB1诱导巨噬细胞产生ROS和IL1β,后者反过来降低CRC细胞中的MPG,放大两种细胞间的正反馈环路以促进DNA损伤并抑制DNA修复。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Chronic inflammation is a risk factor in colorectal cancer (CRC) and reactive oxygen species (ROS) released by the inflamed stroma elicit DNA damage in epithelial cells. We sought to identify new drivers of ulcerative colitis (UC) and inflammatory CRC. DESIGN: The study uses samples from patients with UC, mouse models of colitis and CRC and mice deficient for the epithelial-to-mesenchymal transition factor ZEB1 and the DNA repair glycosylase N-methyl-purine glycosylase (MPG). Samples were analysed by immunostaining, qRT-PCR, chromatin immunoprecipitation assays, microbiota next-generation sequencing and ROS determination. RESULTS: ZEB1 was induced in the colonic epithelium of UC and of mouse models of colitis. Compared with wild-type counterparts, Zeb1-deficient mice were partially protected from experimental colitis and, in a model of inflammatory CRC, they developed fewer tumours and exhibited lower levels of DNA damage (8-oxo-dG) and higher expression of MPG. Knockdown of ZEB1 in CRC cells inhibited 8-oxo-dG induction by oxidative stress (H2O2) and inflammatory cytokines (interleukin (IL)1β). ZEB1 bound directly to the MPG promoter whose expression inhibited. This molecular mechanism was validated at the genetic level and the crossing of Zeb1-deficient and Mpg-deficient mice reverted the reduced inflammation and tumourigenesis in the former. ZEB1 expression in CRC cells induced ROS and IL1β production by macrophages that, in turn, lowered MPG in CRC cells thus amplifying a positive loop between both cells to promote DNA damage and inhibit DNA repair. CONCLUSIONS: ZEB1 promotes colitis and inflammatory CRC through the inhibition of MPG in epithelial cells, thus offering new therapeutic strategies to modulate inflammation and inflammatory cancer.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. de Barrios O, Sanchez-Moral L, Cortés M, et al. ZEB1 promotes inflammation and progression towards inflammation-driven carcinoma through repression of the DNA repair glycosylase MPG in epithelial cells. Gut. 2019. PMID: 31366457. doi:10.1136/gutjnl-2018-317294

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。